FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/08/072847 [Registered on: 21/08/2024] Trial Registered Prospectively
Last Modified On: 21/08/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Unani 
Study Design  Single Arm Study 
Public Title of Study   Effect of herbal formulation in the management of knee osteoarthritis 
Scientific Title of Study   A clinical study to evaluate the efficacy and safety of unani formulation in the management of waja-al-rakba(knee OA)  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  ARJU KAUSHAR 
Designation  PG Scholar 
Affiliation  State takmeel ut-tib college and hospital lucknow 
Address  OPD NUMBER 102 Department of Moalajat State Takmeel-ut-tib Hospital Near Ramabai Rally Sthal Aurangabad Tiraha Lucknow

Lucknow
UTTAR PRADESH
226002
India 
Phone  9695231412  
Fax    
Email  drarzooakhtar1993@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Abdul Qadir 
Designation  Associate professor 
Affiliation  State takmeel ut-tib college and hospital Lucknow  
Address  Department of moalajat State takmeel ut-tib college and hospital Lucknow

Lucknow
UTTAR PRADESH
226002
India 
Phone  9415757169  
Fax    
Email  aq.ayaz5775@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Abdul Qadir 
Designation  Associate professor 
Affiliation  State takmeel ut-tib college and hospital Lucknow  
Address  Department of moalajat State takmeel ut-tib college and hospital Lucknow

Lucknow
UTTAR PRADESH
226002
India 
Phone  9415757169  
Fax    
Email  aq.ayaz5775@gmail.com  
 
Source of Monetary or Material Support  
State takmeel-ut-tib college and hospital Near Ramabai Rally Sthal Aurangabad Tiraha Lucknow Uttar Pradesh India 226002 
 
Primary Sponsor  
Name  STATE TAKMEELUTTIB COLLEGE AND HOSPITAL 
Address  Near Ramabai Rally Sthal Aurangabad Tiraha Lucknow Uttar Pradesh India 226002 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR ARJU KAUSHAR  STATE TAKMEEL UT-TIB COLLEGE AND HOSPITAL  OPD NUMBER 102 DEPARTMENT OF MOALAJAT NEAR RAMABAI RALLY STHAL AURANGABAD TIRAHA 226002
Lucknow
UTTAR PRADESH 
9695231412

drarzooakhtar1993@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committee STATE TAKMEEL UTTIB COLLEGE   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M170||Bilateral primary osteoarthritis of knee, (2) ICD-10 Condition: M179||Osteoarthritis of knee, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  not applicable  not applicable 
Intervention  Orally Unani Polyherbal powder (Suranjan sheerin,Bozidan,Anisoon,Shahtrah,Zanjabeel,Filfil siyah) Locally Araq-ajeeb  6gm polyherbal powder BD daily for 3months 2 to 3 drops of Araq-e-ajeeb locally BD daily for 3 months 
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients of any sex in the age group between 30 to 60 year.
Patients with clinically diagnosed waja-al rakba(Knee OA) on the basis of WOMAC Osteoarthritis Index.
Kellgren and Lawrence classification system based on Radiological finding. 
 
ExclusionCriteria 
Details  Pregnancy and lactating women.
Patients with systemic and metabolic diseases.
Patients unsure about attending treatment schedule regularly.
Patients with the history of trauma and accidents. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The response to treatment will be assessed using the following parameters
Reduction in WOMAC Osteoarthritis Index
Improvement in Investigator Global Assessment(Based on radiological finding) 
3months 
 
Secondary Outcome  
Outcome  TimePoints 
SGOT
SGPT
ALKALINE PHOSPHATASE
BLOOD UREA
SERUM CREATININE
RANDOM BLOOD SUGAR
COMPLETE BLOOD COUNT
ESR  
3 MONTHS  
 
Target Sample Size   Total Sample Size="66"
Sample Size from India="66" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="60" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   02/09/2024 
Date of Study Completion (India) 18/07/2025 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Osteoarthritis is the second most common rheumatic problem and it is the most frequent joint disease with a prevalence of 22%to 39% in India. OA is more common in women than men,but the prevalence increases with age .Nearly,45% of women over the age of 65 year have symptoms while radio logical evidence is found in 70% of those over 65 years. OA was estimated to be the 10th leading cause of nonfatal burden. OA of the knee is more prevalent as per the literature available. Therefore for finding the current burden of OA it is essential to undertake such clinical study.Although various treatment modalities are available in conventional system of medicine ,but  have got some limitations with serious complications such as gastrointestinal toxicity and ulcers.

In Unani system of medicine the basic pathology of the disease is the accumulation of morbid matter due to weakness of the joint. The weakness of the particular joint is  either primarily due to su-e- mizaj(Impaired Temperament) or secondary to injury or heavy work. The general principal of management is Tadeel-e-sueMizaj(Moderation of abnormal temperament), evacuation of Khilte Ghaleez(Morbid Matter) and Taqwiyat.As far as the treatment of Waja’al- Mafasil is concerned the unani physicians have successfully managed this disease since ancient time by adopting various treatment modalities for evacuating the khilte ghaleez (morbid matter) which is achieved by Munzij -Mushil therapy.For this purpose they used lots of single drug in decoction form such as Aslussoos, Suranjan, Bozidan, Reesha Khatmi, Anisoon, Badranjboya, Sana, Turbud, etc.

For local application they used mucilagenous drugs having hot temperament (Hulba & Alsee) in the form of Dimad (Poultice) & Roghan such as Roghane Arand, Roghane Qust, Roghane Sumbul.They also used a number of regimes such as Fasd (venesection), Hijama (Cupping), Dalk (Massage) and Riyadat (Exercise) .

The primary goal of treatment in  OA is to relieve discomfort by controlling symptoms and signs.For this purpose a unani formulation containing Suranjan sheerin, Bozidan, Anisoon, Filfil Siyah, Zanjabeel in oral form whereas Araq-e- Ajeeb in local form will be used to the participants.These formulations possess Musakkin-al-waja(Analgesic), Muaddil-e-dum (Blood alterative), Muhallil(Resolvent), Muqawwi asab (Nervine tonic) etc but their efficacy and safety has yet to be proved on the basis of scientific parameters.

Keeping the above facts in views,it has been planned to conduct a clinical trial entitled “ A Clinical study to evaluate the efficacy & safety of Unani formulation in the management of  Waja’al-rakba (Knee OA).”

 

 
Close